Universe Pharmaceuticals Inc
UPC
Last
$4.07
Day
-2.6%
1y
-42.1%
5y
-100.0%
52w
-76.7%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
4.47
EMA 50
4.58
EMA 200
13.84
20d high
-17.1%
5y high
-100.0%
5y range
0th
Positions held
Your positionsUPC isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-30
Hold
avoid
Signal
Strong Sell
Target
$4.80
Stop
$3.66
Stop distance
10.1%
Target vs last
+17.9%
Fundamentals
| Market cap | $21.00M | Enterprise value | -$17.14M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 0.04 | Beta | 1.68 | Dividend yield | 0.00% |
| Revenue growth | -1.3% | Earnings growth | — | Gross margin | 36.5% | Operating margin | -16.6% |
| Profit margin | -10.9% | ROE | -3.5% | ROA | -1.7% | Debt / equity | 0.17 |
| Current ratio | 4.05 | Free cash flow | -$21.43M | Analyst recommendation | none | Mean target | — |
| 52w high | $17.96 | 52w low | $2.00 |
Quarterly
No data yet.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $17.9M | $23.0M | $32.3M | $40.1M |
| Op margin | -16.3% | -34.8% | -12.3% | -17.5% |
| Net income | -$3.7M | -$8.7M | -$6.6M | -$7.9M |
| Gross margin | 35.3% | 26.4% | 31.9% | 54.5% |
| Gross profit | $6.3M | $6.1M | $10.3M | $21.9M |
| Operating income | -$2.9M | -$8.0M | -$4.0M | -$7.0M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-29 · Universe Pharmaceuticals Files $200 Million Mixed Shelf
2026-09-02 · Top Premarket Gainers
2026-09-02 · Universe Pharmaceuticals Shares Rise 22.6% Premarket With No New Catalyst Identified
2026-08-03 · Top Premarket Gainers
Price (daily)
Full chart · RSI · MACD · patternsUPC · daily-10.4% over 13 sessions
Close EMA21 EMA50 EMA200